PlainRecalls
FDA Devices Moderate Class II Terminated

Coulter DxH Diluent, Catalog No. 628017 Blood cell analysis comprises diluting a whole-blood sample with a solution that functions as a diluent. The diluent provides the ability to analyze portions of the diluted blood sample for different blood cell types and the measurement of hemoglobin.

Reported: September 24, 2014 Initiated: August 25, 2014 #Z-2651-2014

Product Description

Coulter DxH Diluent, Catalog No. 628017 Blood cell analysis comprises diluting a whole-blood sample with a solution that functions as a diluent. The diluent provides the ability to analyze portions of the diluted blood sample for different blood cell types and the measurement of hemoglobin.

Reason for Recall

Beckman Coulter is recalling Coulter DxH Diluent because it may be associated with elevated platelet (PLT) background counts between 3-7 x 10(3) cells/uL. This will result in failed Daily Checks on the UniCel DxH 800 and DxH 600 Coulter Cellular Analysis Systems.

Details

Recalling Firm
Beckman Coulter Inc.
Units Affected
46,050 units total (40,078 units in US)
Distribution
Worldwide Distribution - USA (nationwide) and Internationally to Canada, Chile, Mexico, Panama, and Thailand. .
Location
Brea, CA

Frequently Asked Questions

What product was recalled?
Coulter DxH Diluent, Catalog No. 628017 Blood cell analysis comprises diluting a whole-blood sample with a solution that functions as a diluent. The diluent provides the ability to analyze portions of the diluted blood sample for different blood cell types and the measurement of hemoglobin.. Recalled by Beckman Coulter Inc.. Units affected: 46,050 units total (40,078 units in US).
Why was this product recalled?
Beckman Coulter is recalling Coulter DxH Diluent because it may be associated with elevated platelet (PLT) background counts between 3-7 x 10(3) cells/uL. This will result in failed Daily Checks on the UniCel DxH 800 and DxH 600 Coulter Cellular Analysis Systems.
Which agency issued this recall?
This recall was issued by the FDA Devices on September 24, 2014. Severity: Moderate. Recall number: Z-2651-2014.